Connolly Lynn 4
4 · Adagio Therapeutics, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Connolly Lynn
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-30+175,000→ 175,000 totalExercise: $6.78Exp: 2032-01-29→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.